Study EC + VLNC CC for Smoking/Cigarette Smoking

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Duke University Medical Center, Durham, NCSmoking/Cigarette Smoking+3 Morevery low nicotine content cigarettes - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trialwill investigate how reducing nicotine in cigarettes affects smokers' choices between regular cigarettes & e-cigarettes.

Eligible Conditions
  • Electronic Cigarette Use
  • Smoking/Cigarette Smoking
  • Nicotine Addiction
  • Smoking

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Nicotine Replacement
1
Cigarette A
1
ECIG Lab Session, 30 watts

Study Objectives

1 Primary · 8 Secondary · Reporting Duration: during preference session, approximately 2 hours

Hour 2
CO boost
Cigarette Evaluation Scale
Craving
Cross Price Elasticity
Number of choices for CC during preference task
Number of choices for EC during preference task
Number of choices to abstain during preference task
Perceived health risk
Product Valuation

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Nicotine Replacement
1
Cigarette A
1
ECIG Lab Session, 30 watts

Trial Design

4 Treatment Groups

Study EC + NNC CC
1 of 4
Study EC + UB CC
1 of 4
Own EC + UB CC
1 of 4
Study EC + VLNC CC
1 of 4

Active Control

Experimental Treatment

36 Total Participants · 4 Treatment Groups

Primary Treatment: Study EC + VLNC CC · No Placebo Group · N/A

Study EC + VLNC CCExperimental Group · 2 Interventions: very low nicotine content cigarettes, Study e-cigarette · Intervention Types: Other, Other
Study EC + NNC CCActiveComparator Group · 2 Interventions: normal nicotine content cigarettes, Study e-cigarette · Intervention Types: Other, Other
Study EC + UB CC
Other
ActiveComparator Group · 1 Intervention: Study e-cigarette · Intervention Types: Other
Own EC + UB CCNoIntervention Group · 1 Intervention: Own EC + UB CC · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: during preference session, approximately 2 hours

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,269 Previous Clinical Trials
2,032,315 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,468 Previous Clinical Trials
24,580,862 Total Patients Enrolled
Duke UniversityLead Sponsor
2,207 Previous Clinical Trials
3,220,753 Total Patients Enrolled
Francis McClernon, Ph.D.Principal InvestigatorDuke University

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You usually use e-cigarettes with tobacco-flavored liquid.
References

Frequently Asked Questions

Is recruitment for this medical experiment open at the present time?

"Indeed, clinicaltrials.gov indicates that this research project is currently open for recruitment; the trial was first publicized on October 12th 2022 and has since been updated on November 28th 2022." - Anonymous Online Contributor

Unverified Answer

What is the current anticipated enrollment for this clinical experiment?

"Affirmative. Clinicaltrials.gov's information indicates that this clinical trial is currently recruiting participants, first posted on the 12th of October and last updated November 28th 2022. The research seeks 36 individuals to be involved in a single site study." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top